Antipsychotic Agents: all 1,814 studies that test it

Page 2 of 19. Open to participants first (97), then studies with results posted, then the rest; newest registration first within each.

• Pediatric Oncology Nutrition Intervention TrialCompletedNCT06175273Phase 2/3Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of SchizophreniaCompletedNCT06107803Phase 1Results posted
• The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory SurgeryCompletedNCT05676294Phase 2Results posted
• C-Cog in Early Course Schizophrenia StudyTerminatedNCT05662306Phase 4Results posted
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and AdultsCompletedNCT05615220Phase 3Results posted
• Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and VomitingTerminatedNCT05590923Phase 4Results posted
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum DisorderTerminatedNCT05555615Phase 2/3Results posted
• Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum DisorderCompletedNCT05523895Phase 2/3Results posted
• Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With SchizophreniaTerminatedNCT05368558Phase 3Results posted
• Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With MenopauseCompletedNCT05325775Phase 1/2Results posted
• Haloperidol, Droperidol, Ondansetron in Cannabis HyperemesisTerminatedNCT05065567Phase 3Results posted
• Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic DepressionCompletedNCT04876521Phase 4Results posted
• Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedNCT04819776Phase 3Results posted
• Enhancing the Effects of Alcohol Treatment With LamotrigineCompletedNCT04770493Phase 2Results posted
• A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by KetamineCompletedNCT04602221Phase 1Results posted
• Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell TransplantsCompletedNCT04535141Phase 3Results posted
• Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaCompletedNCT04531982Phase 3Results posted
• Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology PatientsTerminatedNCT04503668Phase 3Results posted
• Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)CompletedNCT04492956Phase 2Results posted
• Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone ImplantCompletedNCT04418466Phase 1/2Results posted
• Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)CompletedNCT04327843Phase 3Results posted
• Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease PsychosisCompletedNCT04292223Phase 4Results posted
• Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia EpisodeTerminatedNCT04203056Phase 4Results posted
• Risperidone for the Treatment of Huntington's Disease Involuntary MovementsCompletedNCT04201834Phase 2Results posted
• Pimavanserin for Insomnia In Veterans With Posttraumatic Stress DisorderCompletedNCT04188392Phase 4Results posted
• Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose QuetiapineTerminatedNCT04164758Phase 2Results posted
• Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia NervosaCompletedNCT04128683Early Phase 1Results posted
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label ExtensionCompletedNCT04114539Phase 2Results posted
• A Study of Paliperidone Palmitate 6-Month FormulationCompletedNCT04072575Phase 3Results posted
• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 DisorderCompletedNCT04030143Phase 1/2Results posted
• Ecopipam Tablets to Study Tourette's Syndrome in Children and AdolescentsCompletedNCT04007991Phase 2Results posted
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant TreatmentTerminatedNCT04000009Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral RisperidoneCompletedNCT03978832Phase 4Results posted
• Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant TreatmentCompletedNCT03968159Phase 3Results posted
• The Use of Trifluoperazine in Transfusion Dependent DBATerminatedNCT03966053Phase 1/2Results posted
• 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar DisorderCompletedNCT03902613Phase 4Results posted
• A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaCompletedNCT03893825Phase 3Results posted
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®TerminatedNCT03892889Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label ExtensionCompletedNCT03870880Phase 3Results posted
• Lamotrigine in Reducing Psychologic Side-Effect of Perioperative KetamineCompletedNCT03831854Phase 3Results posted
• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I DisorderTerminatedNCT03768726Phase 3Results posted
• The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCompletedNCT03739203Phase 3Results posted
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCompletedNCT03738215Phase 3Results posted
• Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedNCT03689114Phase 4Results posted
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's DisorderTerminatedNCT03661983Phase 4Results posted
• Brain Dopamine Function in Human ObesityCompletedNCT03648892Early Phase 1Results posted
• TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency SettingCompletedNCT03639558Phase 4Results posted
• Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHDTerminatedNCT03638466Phase 2Results posted
• A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaCompletedNCT03627195Phase 1Results posted
• Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseCompletedNCT03623321Phase 3Results posted
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD TreatmentTerminatedNCT03597503Phase 3Results posted
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With SchizophreniaTerminatedNCT03593213Phase 3Results posted
• A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseCompletedNCT03575052Phase 3Results posted
• A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed FeaturesCompletedNCT03573297Phase 3Results posted
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
• Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCompletedNCT03503318Phase 3Results posted
• Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer PatientsCompletedNCT03489551Phase 4Results posted
• Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and DepressionCompletedNCT03482882Phase 2Results posted
• CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)CompletedNCT03408873Phase 4Results posted
• Treatment of Refractory Nausea and Vomiting in Patients With Breast CancerCompletedNCT03367572Phase 3Results posted
• A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of SchizophreniaCompletedNCT03345979Phase 3Results posted
• A Study of Paliperidone Palmitate 6-Month FormulationCompletedNCT03345342Phase 3Results posted
• Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male AdultsCompletedNCT03342963Phase 1Results posted
• Relapse Prevention Study of Pimavanserin in Dementia-related PsychosisCompletedNCT03325556Phase 3Results posted
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaCompletedNCT03323437Phase 4Results posted
• Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaTerminatedNCT03230864Phase 3Results posted
• Mechanisms of Refractory Hypertension (Reserpine)CompletedNCT03223272Phase 2Results posted
• Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific AntagonistCompletedNCT03218969Phase 1/2Results posted
• Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major DepressionCompletedNCT03207438Phase 4Results posted
• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831CompletedNCT03201757Phase 3Results posted
• Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderCompletedNCT03187769Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute SchizophreniaCompletedNCT03160521Phase 3Results posted
• Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer PatientsCompletedNCT03137121Phase 2/3Results posted
• Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaTerminatedNCT03121586Phase 3Results posted
• A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's DiseaseCompletedNCT03118947Phase 2Results posted
• Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for AgitationTerminatedNCT03110900Phase 4Results posted
• Olanzapine for Acute HeadachesCompletedNCT03066622Phase 4Results posted
• Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerActive, not recruitingNCT03021486Phase 2/3Results posted
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)CompletedNCT03018340Phase 2Results posted
• Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)TerminatedNCT02992132Phase 2Results posted
• Melancholic Symptoms in Bipolar Depression and Responsiveness to LamotrigineCompletedNCT02989727Phase 4Results posted
• Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRDCompletedNCT02977299Phase 4Results posted
• Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency DepartmentTerminatedNCT02972502Phase 4Results posted
• Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)CompletedNCT02970305Phase 2Results posted
• Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)CompletedNCT02970292Phase 3Results posted
• Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsCompletedNCT02960763Phase 4Results posted
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine HydrochlorideCompletedNCT02943213Phase 1Results posted
• Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose MelphalanCompletedNCT02939287Phase 3Results posted
• Aripiprazole for Bipolar Disorder and Alcohol Use DisorderCompletedNCT02918370Phase 3Results posted
• Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive EpisodeCompletedNCT02918097Phase 4Results posted
• Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.CompletedNCT02876900Phase 3Results posted
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02873208Phase 3Results posted
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood DysregulationCompletedNCT02845453Phase 4Results posted
• A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy SubjectsCompletedNCT02821338Phase 1Results posted
• Safety and Tolerability of Risperidone ImplantsCompletedNCT02773576Phase 3Results posted
• Olanzapine for Nausea After SurgeryCompletedNCT02755116Phase 2Results posted
• Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDDCompletedNCT02720198Phase 3Results posted
• Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaCompletedNCT02717195Phase 3Results posted
• Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02717130Not applicableResults posted
• Characterization of Epilepsy Patients BEEP 2bCompletedNCT02707965Phase 1Results posted

← Antipsychotic Agents overview